Sfoglia per Autore
[The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
1978 Surrenti C;Arcangeli A;Casini A
Histochemical, immunological, electron microscopic study in HBsAg patients with liver diseases and healthy carriers.
1979 Surrenti C;Anselmucci V;Bianchini G;Casini A;Ramarli D;Salvadori G;Gentilini P
Effect of bile acids on E rosette formation and PHA stimulation.
1980 Surrenti C;Casini A;Ramarli D
Studies of cell-mediated immunity in patients with Crohn's disease.
1981 Surrenti C;Ramarli D;Casini A;Scartabelli S;Campi P;Fani A;Nieri S
High-performance liquid chromatographic determination of hydroxyproline after derivatization with 4-dimethylaminoazobenzene-4'-sulphonyl chloride.
1982 Casini A;Martini F;Nieri S;Ramarli D;Franconi F;Surrenti C
Abnormalities of immunocompetent cells in primary biliary cirrhosis.
1982 Ramarli D;Canonica GW;Melioli G;Biagioni P;Nieri S;Casini A;Surrenti C
High Performance Liquid Chromatographic Method for Prostaglandin E2 Determination in Human Gastric Juice Without Derivatization
1984 C.Surrenti; O.E.Ricci; A.Casini; L.Ventura; S.Nieri
Effect of PGE2 and indomethacin on human fibroblast collagen production.
1984 Casini A;Nieri S;Banchetti E;Ricci OE;Calabrò A;Surrenti C
Calcitonin increases peripheral plasma somatostatin-like immunoreactivity levels in humans.
1984 Calabrò A;Strazzulla G;Cappelli G;Casini A;Bartoli U;Brocchi A;Ceccatelli P;Surrenti C
Long term follow-up of mild chronic active hepatitis.
1984 Surrenti C;Salvadori G;Casini A;Nieri S;Ricci OE;Ceccatelli P;Parenti S;Patussi V;Gentilini P
Immune mechanisms for hepatic fibrogenesis. T-lymphocyte-mediated stimulation of fibroblast collagen production in chronic active hepatitis
1985 A.Casini; O.E. Ricci; F.Paoletti; C.Surrenti
Diagnostic significance of anti-HBc IgM (RIA) in healthy HBsAg carriers and in chronic hepatitis B.
1986 Surrenti C;Ambu S;Patussi V;Milani S;Casini A;Zacchi P;Ceccatelli P;Cefaratti C;D'Agata A
Cell-mediated immunity to HBcAg in chronic HBV infection.
1987 Casini A;Alberti A;Banchetti E;Schiavon E;Patussi V;Pontisso P;Surrenti C;Realdi G
Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
1987 Surrenti C;Casini A;Milani S;Ambu S;Ceccatelli P;D'Agata A
Serum HBV DNA and intrahepatic hepatitis B core antigen (HBcAg) in chronic hepatitis B virus infection: correlation with infectivity and liver histology.
1988 S. Milani;S. Ambu;V. Patussi;A. D'Agata;M. Labardi;G. Salvadori;C. Surrenti
Enzyme immunoassay of gastric luminal prostaglandin E2 in duodenal ulcer disease
1989 CALABRO A; ORSINI B; FEDI P; M. FALCHINI; SURRENTI C
Culture of fibroblast-like cells derived from normal human liver. Identification by morphologic and immunologic criteria.
1989 Casini A;Dini G;Banchetti E;Grappone C;Surrenti C
S-adenosylmethionine inhibits collagen synthesis by human fibroblasts in vitro.
1989 Casini A;Banchetti E;Milani S;Maggioni Moratti E;Surrenti C
Cigarette smoking increases gastric luminal prostaglandin F2 alpha and thromboxane B2 in healthy smokers.
1990 P. Fedi;A. Calabrò;B. Orsini;S. Milani;P. Zacchi;G. Salvadori;C. Surrenti
Gastric juice immunoreactive epidermal growth factor levels in patients with peptic ulcer disease
1990 CALABRO A; ORSINI B; BROCCHI A; M. FALCHINI; FEDI P; SURRENTI C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile